Abstract:Over the last few decades, an alarming rise in the percentage of individuals with cancer and those with multi-resistant illnesses has forced researchers to explore possibilities for novel therapeutic approaches. Numerous medications currently exist to treat various disorders, and the development of small molecules as anticancer agents has considerable potential. However, the widespread prevalence of resistance to multiple drugs in cancer indicates that it is necessary to discover novel and promising compounds with ideal characteristics that could overcome the multidrug resistance issue. The utilisation of metallo-drugs has served as a productive anticancer chemotherapeutic method, and this approach may be implemented for combating multi-resistant tumours more successfully. Schiff bases have been receiving a lot of attention as a group of compounds due to their adaptable metal chelating abilities, innate biologic properties, and versatility to tweak the structure to optimise it for a specific biological purpose. The biological relevance of Schiff base and related complexes, notably their anticancer effects, has increased in their popularity as bio-inorganic chemistry has progressed. As a result of learning about Schiff bases antitumor efficacy against multiple cancer cell lines and their complexes, researchers are motivated to develop novel, side-effect-free anticancer treatments. According to study reports from the past ten years, we are still seeking a powerful anticancer contender. This study highlights the potential of Schiff bases, a broad class of chemical molecules, as potent anticancer agents. In combination with other anticancer strategies, they enhance the efficacy of treatment by elevating the cytotoxicity of chemotherapy, surmounting drug resistance, and promoting targeted therapy. Schiff bases also cause cancer cell DNA repair, improve immunotherapy, prevent angiogenesis, cause apoptosis, and lessen the side effects of chemotherapy. The present review explores the development of potential Schiff base and their d and f block metal complexes as anticancer agents against various cancer cell lines.

Recent development of Schiff-base metal complexes as therapeutic agents for lung cancer

Construction of Arsenic-Metal Complexes Loaded Nanodrugs for Solid Tumor Therapy: A Mini Review.

Organometallic gold(I) and gold(III) complexes for lung cancer treatment

Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies

Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment

Current status of iridium-based complexes against lung cancer

Ruthenium Complexes as Promising Candidates against Lung Cancer

Review: Recent Advances and Future Development of Metal Complexes As Anticancer Agents

Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy

Recent Advances of Metal Complexes in the Treatment of Hepatocellular Carcinoma

An Insight into the Effect of Schiff Base and their d and f Block Metal Complexes on Various Cancer Cell Lines as Anticancer Agents: A Review

Schiff Bases and their Metal Complexes as Potential Anticancer Candidates: A Review of Recent Works

Recent Advances in Ruthenium and Platinum Based Supramolecular Coordination Complexes for Antitumor Therapy

Metal-N-heterocyclic carbene complexes as anti-tumor agents

Transition metal complexes with tetradentate Schiff bases (N 2 O 2 ) obtained from salicylaldehyde: A review of their possible anticancer properties

A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies

Gold complexes: a new frontier in the battle against lung cancer

Supramolecular Coordination Complexes As Diagnostic and Therapeutic Agents

Metal-based Anticancer Chemotherapeutic Agents.

Recent Developments In Organometallic Supramolecular Complexes As Anticancer Drugs

Research progress of natural product-conjugated platinum and gold complexes as potential antitumor agents